Sonnet BioTherapeutics
SONN
SONN
20 hedge funds and large institutions have $532K invested in Sonnet BioTherapeutics in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
20
Holders Change
+5
Holders Change %
+33.33%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
1
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Stifel Financial
St. Louis,
Missouri
|
$25K |
2 |
2
Citadel Advisors
Miami,
Florida
|
$15K |
3 |
VKH
3
Virtu KCG Holdings
New York
|
$9K |
4 |
4
First Manhattan
New York
|
$3K |
5 |
5
Barclays
London,
United Kingdom
|
$2K |